- Home
- BSET vs SGMO Comparison
BSET vs SGMO Comparison
Compare BSET & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSET
- SGMO
- Stock Information
- Founded
- BSET 1902
- SGMO 1995
- Country
- BSET United States
- SGMO United States
- Employees
- BSET N/A
- SGMO N/A
- Industry
- BSET Home Furnishings
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSET Consumer Discretionary
- SGMO Health Care
- Exchange
- BSET Nasdaq
- SGMO Nasdaq
- Market Cap
- BSET 135.3M
- SGMO 122.8M
- IPO Year
- BSET 1987
- SGMO 2000
- Fundamental
- Price
- BSET $15.50
- SGMO $0.66
- Analyst Decision
- BSET
- SGMO Strong Buy
- Analyst Count
- BSET 0
- SGMO 7
- Target Price
- BSET N/A
- SGMO $5.29
- AVG Volume (30 Days)
- BSET 24.8K
- SGMO 5.5M
- Earning Date
- BSET 10-08-2025
- SGMO 11-11-2025
- Dividend Yield
- BSET 5.21%
- SGMO N/A
- EPS Growth
- BSET N/A
- SGMO N/A
- EPS
- BSET 0.28
- SGMO N/A
- Revenue
- BSET $326,469,000.00
- SGMO $81,706,000.00
- Revenue This Year
- BSET $3.18
- SGMO $28.47
- Revenue Next Year
- BSET $3.57
- SGMO N/A
- P/E Ratio
- BSET $54.60
- SGMO N/A
- Revenue Growth
- BSET N/A
- SGMO 565.52
- 52 Week Low
- BSET $13.58
- SGMO $0.41
- 52 Week High
- BSET $19.75
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- BSET 39.05
- SGMO 68.35
- Support Level
- BSET $15.51
- SGMO $0.65
- Resistance Level
- BSET $16.20
- SGMO $0.73
- Average True Range (ATR)
- BSET 0.47
- SGMO 0.06
- MACD
- BSET -0.04
- SGMO 0.01
- Stochastic Oscillator
- BSET 2.42
- SGMO 72.69
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.